Legend Biotech Corp
LEGN · Pharmaceutical Preparations
Latest available SEC filing: 4 ·
Latest disclosures
-
Sanders Corazon (Corsee) D.: Form 4
Insider disclosure · Filed · Report period 29 Sep 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Latest financial period: Q4 2025
Financial facts · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- LEGN · 52490G102 - COMMON STOCK
Company details and SEC sources
CIK 0001801198 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- LEGN on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 2101 Cottontail Lane, Somerset, NJ, 08873
- Incorporated in
- Cayman Islands
- Fiscal year end
- 31 December
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields